Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A screening method for nucleic acid aptamers specifically binding to alpha-fetoprotein

A nucleic acid aptamer and alpha-fetoprotein technology, applied in the field of analytical chemistry, can solve the problems of immunogenicity and high cost of antibodies

Inactive Publication Date: 2016-06-15
ZHONGSHAN HOSPITAL FUDAN UNIV +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the qualitative and quantitative detection of AFP in clinical and scientific research mostly relies on antibodies. Although the sensitivity and specificity are high, antibodies have disadvantages such as high cost and immunogenicity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A screening method for nucleic acid aptamers specifically binding to alpha-fetoprotein
  • A screening method for nucleic acid aptamers specifically binding to alpha-fetoprotein
  • A screening method for nucleic acid aptamers specifically binding to alpha-fetoprotein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Example 1 Screening of nucleic acid aptamers

[0026] 1. Instruments and materials: P / ACEMDQ capillary electrophoresis instrument (Beckman-Coulter, USA), equipped with diode array (PDA) and laser-induced fluorescence (LIF) detectors; PVA-coated elastic quartz capillary column with a total length of 40cm and an effective length of 30cm , with an inner diameter of 50 μm and an outer diameter of 360 μm.

[0027] 2. Electrophoresis buffer preparation: use ultrapure water to prepare 30mM NaH 2 PO 3 , adjusted the pH value to 7.5 with 1M NaOH solution, and filtered through a 0.45 μm membrane filter.

[0028] 3. Design and synthesize a random oligonucleotide library with a full length of 75 bases, the sequence is shown in SEQ ID NO.1, 5'-GTGACGCTCCTAACGCTGAC-35N-CCTGTCCGTCCGAACCAATC-3', and the two ends are fixed with 20 bases respectively Sequence, the middle 35 bases are random sequences.

[0029] 4. Synthesize upstream primers and downstream primers for PCR amplificat...

Embodiment 2

[0038] Cloning and sequencing of embodiment 2 nucleic acid aptamers

[0039] Prepare the following solutions in a microcentrifuge tube, the total volume is 5 μl: pMD19-TVector 1 μl, oligonucleotide PCR product 0.2 pmol, ddH 2O supplemented to 5 μl. Add 5 μl of SolutionI. React at 16°C for 30 minutes. The whole amount (10 μl) was added to 100 μl Trans5α competent cells, and placed in ice for 30 minutes. After heating at 42°C for 45s, place in ice for 1min. Add 890 μl LB medium, shake and culture at 37°C for 60min. Culture on LB agar plate medium containing X-Gal, IPTG and Amp at 37°C to form a single colony. Select white monoclonal colonies and put them into 2ml LB (Amp80μg / ml) liquid medium, shake and culture at 200rpm, 37°C for 16h, and submit the bacterial liquid to Shanghai Sangon for sequencing.

Embodiment 3

[0040] Example 3 Verification of nucleic acid aptamers

[0041] 83 oligonucleotide sequences were obtained by sequencing. After sorting out the sequencing results and predicting the structure, 14 sequences with representative structures were selected for capillary electrophoresis analysis, and one sequence with high specificity, aptamer-273, was selected.

[0042] The sequence of Aptamer-273 is shown in SEQ ID NO.4.

[0043] Investigation 1: Capillary electrophoresis detection of binding specificity between fluorescently labeled aptamer-273 and AFP protein in this example.

[0044] Electrophoresis buffer is 30mMNaH 2 PO 3 , pH7.5, AFP concentration is 0.1mg / ml, aptamer concentration is 10μM. The inner diameter of PVA-coated capillary column is 50 μm, the total length is 40 cm, and the effective length is 30 cm; the separation voltage is -8 kV, the pressure is 34 mbar; the temperature is 25 ° C; the pressure is 34 mbar, and the mixture of fluorescent (FAM)-labeled aptamer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
Login to View More

Abstract

The present invention involves a method of screening nail protein specific nucleic acid ligands using capillary electrical technology, including the following steps: design and build random 寡 nucleotide libraries, combined with capillary electrophoresis technology and SELEX screening method, which is rich and can be available to be ableThe oligonucleotide combined with nail protein, after cloning, sequencing, capillary electrophoretic analysis, and immunofluorescence verification, oligraphy nucleotides that can be combined with taiffendin, that is, the adaptation body.The present invention provides an efficient and special adaptive screening method.The advantage of the present invention is that the advantages of the capacity of the capillary tube are shortened, and the screening time can be shortened, and only 4 rounds of cycle can be completed. At the same time, the non -specific screening caused by the influence is reduced.

Description

technical field [0001] The invention relates to the technical field of analytical chemistry, in particular to a screening method for nucleic acid aptamers specifically binding to alpha-fetoprotein. Background technique [0002] Aptamer (aptamer) is a single-stranded oligonucleotide (ssDNA or RNA) that recognizes target molecules through structure specificity. Its principle of action is similar to that of antibodies, and at the same time, it has the advantages of non-immunogenicity, chemical synthesis, easy modification, low cost, and good stability. It has broad application prospects in clinical diagnosis, new drug development, and basic research. [0003] Aptamer screening technology is named as exponential enrichment ligand system evolution technology, referred to as SELEX (Systematicevolutionofligandbyexponentialenrichment), which is a new combinatorial chemistry technology developed in the early 1990s. The basic idea is: construct an oligonucleotide library in vitro and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68
CPCC12N15/1048C12Q2565/125
Inventor 吴伟忠胡洪卫郭玮冬黎黎谈绮文
Owner ZHONGSHAN HOSPITAL FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com